Semaglutide costs $14 in India, $349 in US after patent expiration enables generic production
Semaglutide, the active ingredient in Ozempic, costs $14 per dose in India compared to $349 in the United States, according to Vox reporting. The source attributes the price difference to India's patent expiration on the drug, which allows local manufacturers to produce generic versions at a fraction of the cost. The analysis examines how patent law and pharmaceutical regulation create divergent drug pricing across markets.
Verified
- ✓Semaglutide costs $14 in India and $349 in the US. (Vox)
- ✓The patent on semaglutide expired in India. (Vox)
- ✓Generic manufacturers in India produce semaglutide at lower cost following patent expiration. (Vox)
Interpretation
- ~Patent expiration is the primary driver of the price differential between US and Indian markets. (Vox analysis)
▸▾Why this is here
- Source
- @vox
- Source type
- Commercial Newsroom (Tier 6)
- Content type
- Reported
- Confidence
- Reported
- Coverage
- Not yet checked
- Published
- April 14, 2026 at 6:26 PM PDT
Confidence labels explain how settled this information is. Learn about our confidence system → · What qualifies a story →
Get stories like this every morning.
Free daily briefing — 5 minutes, no spin.